129 related articles for article (PubMed ID: 37083567)
1. Hepatic Superscan in Methotrexate-Associated Lymphoproliferative Disorder.
Chow TK
Clin Nucl Med; 2023 Jun; 48(6):534-535. PubMed ID: 37083567
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.
Kuramoto R; Hirata K; Takei T; Oridate N; Suzuki S; Yamada Y; Imamura M; Tamaki N
Clin Nucl Med; 2011 Jul; 36(7):582-3. PubMed ID: 21637066
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG hepatic superscan in a patient with chronic myeloid leukemia.
Du B; Li X; Li N; Li Y; Hsu B
Clin Nucl Med; 2014 Sep; 39(9):835-6. PubMed ID: 24662659
[TBL] [Abstract][Full Text] [Related]
5. FDG-Avid But Pentixafor-Negative in EBV-Associated T-Cell Lymphoproliferative Disorders.
Shu Q; He X; Chen Y; Cai L
Clin Nucl Med; 2023 Aug; 48(8):714-715. PubMed ID: 37335307
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT in 2 Cases of Hepatic Pseudolymphoma.
Zhong X; Dong A; Dong H; Wang Y
Clin Nucl Med; 2018 May; 43(5):e166-e169. PubMed ID: 29517544
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
Ikeda K; Nakamura T; Kinoshita T; Fujiwara M; Uose S; Someda H; Miyoshi T; Io K; Nagai K
Clin J Gastroenterol; 2016 Feb; 9(1):17-21. PubMed ID: 26733461
[TBL] [Abstract][Full Text] [Related]
8. FDG Hepatic Superscan Due to Metastatic Infiltration of Prostate Cancer.
Yildirim N; Dede DS; Gumuskaya B
Clin Nucl Med; 2020 Jun; 45(6):474-476. PubMed ID: 32366788
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders.
Takanashi S; Nakazato T; Aisa Y; Ito C; Arakaki H; Osada Y; Hirano M; Mori T
Ann Hematol; 2018 Sep; 97(9):1611-1618. PubMed ID: 29713747
[TBL] [Abstract][Full Text] [Related]
10. Miliary tuberculosis diagnosed by diffuse hepatic uptake on PET/CT and transjugular liver biopsy.
Ueta R; Saito A; Yanai Y; Otake Y; Yokoi C; Akiyama JI; Yanase M; Tajima T
Clin J Gastroenterol; 2024 Jun; 17(3):530-536. PubMed ID: 38532075
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Methotrexate-Induced Lymphoproliferative Disorder.
Kaneyuki D; Iguchi A; Tokunaga C; Fukushima K; Sato T; Nakajima H
Ann Thorac Surg; 2019 Sep; 108(3):e157-e159. PubMed ID: 30853590
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
Kameda T; Nakashima S; Mitamura K; Yamamoto Y; Norikane T; Shimada H; Wakiya R; Kato M; Miyagi T; Sugihara K; Mino R; Mizusaki M; Kadowaki N; Dobashi H
Sci Rep; 2022 Sep; 12(1):15367. PubMed ID: 36100660
[TBL] [Abstract][Full Text] [Related]
13. "Hepatic Superscan" in a Patient With Hepatosplenic Alphabeta T-cell Lymphoma: 18F-FDG PET/CT Findings.
Liu E; Wang S; Lai P; Lian Z; Wang S
Clin Nucl Med; 2018 Aug; 43(8):595-598. PubMed ID: 29762242
[TBL] [Abstract][Full Text] [Related]
14. FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted Kidney.
Yang Y; Wang W; Kan Y; Liu J; Yang J
Clin Nucl Med; 2018 Jun; 43(6):441-444. PubMed ID: 29485445
[TBL] [Abstract][Full Text] [Related]
15. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.
Matsumoto R; Numata K; Doba N; Hara K; Chuma M; Fukuda H; Nozaki A; Tanaka K; Ishii Y; Maeda S
J Med Ultrason (2001); 2016 Oct; 43(4):545-51. PubMed ID: 27577564
[TBL] [Abstract][Full Text] [Related]
16. Hepatic methotrexate-associated lymphoproliferative disorders identified by multiple liver tumors: a case report and review of the literature.
Ono R; Kumagae T; Uojima H; Teshima S; Kudo M; Kitagawa I; Yoshizawa M
J Med Case Rep; 2019 Jun; 13(1):196. PubMed ID: 31242930
[TBL] [Abstract][Full Text] [Related]
17. Solitary Central Nervous System Relapse of Posttransplant Lymphoproliferative Disorder on 18 F-FDG PET/CT.
Feng L; Yang X; Lu X; Wang W; Yang J
Clin Nucl Med; 2022 Nov; 47(11):1007-1009. PubMed ID: 35835131
[TBL] [Abstract][Full Text] [Related]
18. Hepatic tuberculosis: a rare cause of fluorodeoxyglucose hepatic superscan with background suppression on positron emission tomography.
Wong SS; Yuen HY; Ahuja AT
Singapore Med J; 2014 Jul; 55(7):e101-3. PubMed ID: 24347039
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Superscan on 18 F-FDG PET/CT in a Patient With Secondary Hyperparathyroidism.
Mohd Rohani MF; Bujang NL; Rosdi AH; Amir Hassan SZ
Clin Nucl Med; 2024 Jan; 49(1):e19-e21. PubMed ID: 37883221
[TBL] [Abstract][Full Text] [Related]
20. "Hepatic Superscan" Revealed on 18 F-FDG PET Due to Drug-Induced Fulminant Hepatitis.
Qiu G; Shao F; Xie P
Clin Nucl Med; 2024 Jan; 49(1):101-103. PubMed ID: 37976529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
